Education
About Us
Working with TipRanks
Follow Us
Lauren Bullaro Riker Insider Profile
4 Followers
Lauren Bullaro Riker, SVP Finance at Pacira Pharmaceuticals, holds 68.52K shares in Pacira Pharmaceuticals (Ticker: PCRX).
Lauren Bullaro Riker Pacira Pharmaceuticals (PCRX)SVP Finance
Pacira Pharmaceuticals (PCRX)
SVP Finance
Ranked #31,368 out of 100,956 Corporate Insiders
Profitable Transactions
10 out of 16 Profitable Transactions
Average Return
+1.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Lauren Bullaro Riker's holdings
Insider Roles
SVP Finance
Roles that Lauren Bullaro Riker holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 18, 2015 - Mar 18, 2016
Return:+51.20%
The most profitable trade made by Lauren Bullaro Riker
Lauren Bullaro Riker's Trading History
List of latest transactions for each holding click on a transaction to see Lauren Bullaro Riker's performance on stock
You May Also Like
Lauren Bullaro Riker insider profile FAQ
What is the percentage of profitable transactions made by Lauren Bullaro Riker?
The percentage of profitable transactions made by Lauren Bullaro Riker is 63%.
What is the average return per transaction made by Lauren Bullaro Riker?
The average return per transaction made by Lauren Bullaro Riker is 1.80%.
What stocks does Lauren Bullaro Riker hold?
Lauren Bullaro Riker holds: PCRX stocks.
What was Lauren Bullaro Riker’s latest transaction?
Lauren Bullaro Riker latest transaction was an Uninformative Buy of ―.
What was Lauren Bullaro Riker's most profitable transaction?
Lauren Bullaro Riker’s most profitable transaction was an Informative Sell of PCRX stock on March 18, 2015. The return on the trade was 51.20%.
What is Lauren Bullaro Riker's role in Pacira Pharmaceuticals?
Lauren Bullaro Riker's role in Pacira Pharmaceuticals is SVP Finance.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.